TTD

Tinkerine enters Collaboration Agreement with Techies of Tomorrow

Retrieved on: 
星期四, 五月 30, 2024
3D, Partnership, Artificial intelligence, Educational technology, TTD, Agriculture, Housing

Delta, BC, May 30, 2024 (GLOBE NEWSWIRE) -- Tinkerine Studios Ltd. (TSXV: TTD) ("Tinkerine" or the "Company") announces a recent partnership through a Collaboration Agreement with Techies of Tomorrow (“TOT”), a leading technology talent incubator based in British Columbia.

Key Points: 
  • Delta, BC, May 30, 2024 (GLOBE NEWSWIRE) -- Tinkerine Studios Ltd. (TSXV: TTD) ("Tinkerine" or the "Company") announces a recent partnership through a Collaboration Agreement with Techies of Tomorrow (“TOT”), a leading technology talent incubator based in British Columbia.
  • Under this agreement, Tinkerine will expand its portfolio of Education Technology (“Edtech”) products and services to include platform development, artificial intelligence, and 3D printing solutions.
  • The joint efforts between Tinkerine and TOT are currently concentrated on various projects spanning the 3D printing, dental, housing, agriculture, and the medical sectors.

 The Trade Desk Unveils the Sellers and Publishers Report – a Biannual Review of Open Internet Trends

Retrieved on: 
星期三, 五月 29, 2024
Software, Online, Entertainment, Internet, Social Media, Professional Services, Data Management, Technology, Data Analytics, Marketing, Advertising, Communications, Partnership, Big Tech, CTV, News, The Trade Desk, Publishing, Open, Claudia Brant, Sport, TTD, Multimedia, Video game

Global advertising technology leader The Trade Desk (Nasdaq: TTD) today launched The Sellers and Publishers Report – a new biannual assessment of advertising trends on the open internet.

Key Points: 
  • Global advertising technology leader The Trade Desk (Nasdaq: TTD) today launched The Sellers and Publishers Report – a new biannual assessment of advertising trends on the open internet.
  • According to data from The Trade Desk, which assesses more than 15 million advertising opportunities per second on the open internet, the leading 500 digital publishers account for approximately 50 percent of advertising revenue on the open internet.
  • View the full release here: https://www.businesswire.com/news/home/20240529378674/en/
    The Best of the Open Internet (Graphic: Business Wire)
    According to the report, consumers now spend 61 percent of their online time on the open internet, compared to 39 percent within Big Tech walled gardens.
  • To read The Sellers and Publishers Report: The Rise of the Premium Internet and view the Best of the Open Internet list, please visit The Trade Desk website here .

Remission Medical Launches a Navigator Service

Retrieved on: 
星期五, 五月 10, 2024
Insurance, Patient, PIN, CMMI, CMS, Rheumatism, Work, Arthralgia, Practitioner, App, Remission, MD, Autoimmunity, TTD, Arthritis, CDC, Quality of life, TTI, Medicine, Nursing

RICHMOND, Va., May 10, 2024 /PRNewswire/ -- Remission Medical, the largest national virtual clinic offering diagnosis and longitudinal care in Rheumatology, powered by video visits and a technology platform focused on escalation avoidance, is now in its third year.

Key Points: 
  • "A big learning we've had since our founding in 2022 is that not every patient issue rises to the level of a video visit," said Kyle Harner, MD, Chief Medical Officer of Remission Medical.
  • "We knew wait times to see a Rheumatologist for diagnosis and longitudinal care were very long in America," said Blake Wehman, Founder & CEO of Remission Medical.
  • But a significant portion of a patient's journey to low disease activity or remission should occur outside the four walls of a medical office, where texting can be effective and efficient," said Blake Wehman, CEO of Remission Medical and proud Remission Medical patient himself.
  • Remission Medical partners with hospital systems nationwide to speed Time to Diagnosis (TTD) and Time to Treatment Initiation (TTI) in Rheumatic Disease, and is based in Richmond, Virginia.

VerticalScope Partners with The Trade Desk to Integrate OpenPass and OpenPath

Retrieved on: 
星期三, 五月 1, 2024
Data Management, Technology, Publishing, Marketing, Advertising, Communications, Social Media, Security, Search Engine Marketing, Software, Internet, The Trade Desk, Commerce, Trade, TSX, Partnership, TTD, Torstar, Online shopping

OpenPass is a single-sign-on solution created by The Trade Desk that will be deployed across VerticalScope’s web communities, providing users with a secure login alternative.

Key Points: 
  • OpenPass is a single-sign-on solution created by The Trade Desk that will be deployed across VerticalScope’s web communities, providing users with a secure login alternative.
  • As web publishers face concerns related to advertising addressability and consumer privacy, OpenPass allows them to authenticate their users in a transparent manner and provide a premium ad experience.
  • This direct connection will contribute to a more efficient auction, driving value for both advertisers and VerticalScope.
  • “The Trade Desk is an industry leader, and this partnership offers a secure and premium experience to our users, which is why we’re also excited to offer OpenPass as a new login option for our communities.”

Roku and The Trade Desk Announce New Data-Driven TV Streaming Partnership

Retrieved on: 
星期二, 四月 30, 2024
Networks, Internet, Audio, Video, TV and Radio, Advertising, Communications, Technology, Entertainment, The Trade Desk, Household, Ecosystem, Trade, Partnership, SVP, Noise, TTD, Hypothesis, Multimedia

Roku (NASDAQ: ROKU), the #1 TV streaming platform in the U.S.*, announced plans for a new data-driven TV streaming partnership with The Trade Desk (NASDAQ: TTD), the largest independent global advertising technology leader, to equip advertisers with better planning, buying, and measurement of TV streaming media.

Key Points: 
  • Roku (NASDAQ: ROKU), the #1 TV streaming platform in the U.S.*, announced plans for a new data-driven TV streaming partnership with The Trade Desk (NASDAQ: TTD), the largest independent global advertising technology leader, to equip advertisers with better planning, buying, and measurement of TV streaming media.
  • Roku plans to empower advertisers using The Trade Desk with the ability to leverage Roku Media and audience and behavioral data, so that The Trade Desk customers can better understand and optimize their campaigns for TV streaming viewers.
  • View the full release here: https://www.businesswire.com/news/home/20240430850603/en/
    Roku announced plans for a new data-driven TV streaming partnership with The Trade Desk to equip advertisers with better planning, buying, and measurement of TV streaming media.
  • Advertisers can access Roku Media through a range of options in The Trade Desk in a private marketplace.

The Trade Desk Announces Date of First Quarter 2024 Financial Results and Conference Call

Retrieved on: 
星期三, 四月 17, 2024
Technology, Content Marketing, Other Communications, Marketing, Advertising, Communications, Software, Internet, Digital Marketing, Search Engine Marketing, The Trade Desk, ID, Trade, Telephone, Webcast, TTD

The Trade Desk, Inc. (NASDAQ: TTD), a provider of a global technology platform for buyers of advertising, today announced that it will release financial results for the first quarter ended March 31, 2024 after the market closes on Wednesday, May 8, 2024.

Key Points: 
  • The Trade Desk, Inc. (NASDAQ: TTD), a provider of a global technology platform for buyers of advertising, today announced that it will release financial results for the first quarter ended March 31, 2024 after the market closes on Wednesday, May 8, 2024.
  • The Trade Desk will host a webcast and conference call to discuss first quarter financial results at 2:00 P.M. Pacific Time.
  • Webcast: A live webcast of the call can be accessed from the Investor Relations section of The Trade Desk’s website at http://investors.thetradedesk.com/ .
  • The audio replay will be available via telephone until May 15, 2024.

RYBREVANT® (amivantamab-vmjw) data at ELCC advance Johnson & Johnson's ambition to transform the standard of care for patients with EGFR-mutated non-small cell lung cancer

Retrieved on: 
星期一, 三月 18, 2024
Abstract, Lung cancer, EGFR, Neoplasm, ELCC, NSCLC, Science, Progression-free survival, Patient, Amivantamab, Drug, Johnson & Johnson, TTD, PAPILLON, FDA, Pharmaceutical industry

PRAGUE, March 18, 2024 /PRNewswire/ -- Johnson & Johnson announced today that new data will be featured at this year's European Lung Cancer Congress (ELCC) taking place from March 20 to 23 in Prague, Czech Republic, highlighting the Company's commitment to transform the treatment of lung cancer through the ongoing study of RYBREVANT® (amivantamab)-based regimens in the treatment of epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC). Key data to be featured in four mini-oral presentations include results from an exploratory analysis from the Phase 3 MARIPOSA study evaluating the effect of RYBREVANT® dose interruptions on clinical outcomes, new results confirming the recommended dose for monthly subcutaneous administration of amivantamab from the Phase 1b PALOMA study, and post-progression analyses from the pivotal PAPILLON and MARIPOSA-2 studies, which aim to support the differentiated clinical profile of RYBREVANT® in the treatment of patients with EGFR-mutated NSCLC.1,2,3,4

Key Points: 
  • "Following recent regulatory submissions in the U.S. and Europe, we look forward to advancing our transformative portfolio and bringing novel targeted treatment regimens to patients around the world."
  • "The results presented at ELCC reinforce the role RYBREVANT-based treatment regimens may play in improving the standard of care in EGFR-mutated NSCLC," said Henar Hevia, EMEA Therapeutic Area Lead, Oncology, Solid Tumors, Johnson & Johnson Innovative Medicine.
  • "We have made remarkable progress in advancing the science of NSCLC and will continue to evaluate the full potential of RYBREVANT as a treatment for patients through our comprehensive clinical development program."
  • The complete list of Company-sponsored abstracts follows:

Labcorp Presents New Research Demonstrating Clinical Impact of Precision Diagnostics in Guiding Biomarker-targeted Therapies for Patients with Epithelial Ovarian Cancer

Retrieved on: 
星期六, 三月 16, 2024
Diagnosis, Ovarian cancer, MIRV, Mutation, Health, BRCA, Science, Disease, Partnership, Patient, Education, Glomus tumor, Roche, Biomarker, Neoplasm, Research, Cancer, EOC, Recombinant DNA, Woman, HRP, PARP, TTD, Fibroadenoma, HRD, Mirvetuximab soravtansine, BRCA2, Recurrence, LH, BRCA1, ADP, Pharmaceutical industry

BURLINGTON, N.C., March 16, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today presented the results from two studies at the 2024 SGO Annual Meeting on Women's Cancer. The studies demonstrate the value of biomarker testing in closing testing gaps and guiding targeted therapies for patients with epithelial ovarian cancer (EOC).

Key Points: 
  • The studies demonstrate the value of biomarker testing in closing testing gaps and guiding targeted therapies for patients with epithelial ovarian cancer (EOC).
  • Labcorp researchers conducted two studies to generate further evidence of the value of comprehensive genomic profiling to drive guideline-compliant testing that enables increased patient access to targeted therapies for improved outcomes.
  • When combined, the results of BRCA and HRD testing can determine which patients are most likely to benefit from treatment with poly-ADP ribose polymerase (PARP) inhibitors.
  • "This research emphasizes the power of comprehensive biomarker testing in advancing the treatment of ovarian cancer.

The Trade Desk Announces Date of Fourth Quarter and Fiscal Year 2023 Financial Results and Conference Call

Retrieved on: 
星期三, 一月 24, 2024
Software, Digital Marketing, Internet, Marketing, Advertising, Data Management, Communications, Technology, Telephone, The Trade Desk, Trade, ID, TTD, Webcast

The Trade Desk, Inc. (NASDAQ: TTD), a provider of a global technology platform for buyers of advertising, today announced that it will release financial results for the fourth quarter and fiscal year ended December 31, 2023 after the market closes on Thursday, February 15, 2024.

Key Points: 
  • The Trade Desk, Inc. (NASDAQ: TTD), a provider of a global technology platform for buyers of advertising, today announced that it will release financial results for the fourth quarter and fiscal year ended December 31, 2023 after the market closes on Thursday, February 15, 2024.
  • The Trade Desk will host a webcast and conference call to discuss fourth quarter and fiscal year financial results at 2:00 P.M. Pacific Time.
  • Webcast: A live webcast of the call can be accessed from the Investor Relations section of The Trade Desk’s website at http://investors.thetradedesk.com/ .
  • Audio replay: An audio replay of the call will be available beginning about two hours after the call.

The Trade Desk’s Chief Strategy Officer, Samantha Jacobson, Joins the Company’s Board of Directors

Retrieved on: 
星期三, 一月 17, 2024
Marketing, Data Management, Advertising, Digital Marketing, Communications, Technology, Publishing, Entrepreneurship, Pinterest, TTD, Microsoft, Trade, Oracle Advertising, Business administration, University, The Trade Desk, Harvard Business School, Unified, Master of Business Administration, Internet, Management

Global advertising technology leader The Trade Desk (Nasdaq: TTD) today announced that Samantha Jacobson has joined its board of directors.

Key Points: 
  • Global advertising technology leader The Trade Desk (Nasdaq: TTD) today announced that Samantha Jacobson has joined its board of directors.
  • "I’m thrilled to have Samantha join our board of directors," said Jeff Green, CEO and Co-Founder, The Trade Desk.
  • "Samantha has played an important role in advancing key strategic initiatives for The Trade Desk over the last three years, including Unified ID 2.0.
  • Jacobson joined The Trade Desk after six years at Oracle where she managed the global business development and strategy team.